Verition Fund Management
KYNB

Verition Fund Management’s Kyntra Bio KYNB Stock Holding History

Verition Fund Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,700
Closed -$1.58M – 1601
2020
Q4 		$1.58M Buy
+1,700
New +$1.79M 0.01% 422
2019
Q4 		– Sell
-1,200
Closed -$1.11M – 1171
2019
Q3 		$1.11M Sell
1,200
-400
-25% -$439K 0.03% 385
2019
Q2 		$1.81M Buy
+1,600
New +$1.75M 0.05% 263

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
GC
GFG Capital Miami, Florida $363M AUM 45.53% 1-Year Est. Return

Verition Fund Management's KYNB Position: Q3 2024 in Review

Verition Fund Management sold out of Kyntra Bio (KYNB) in Q3 2024, closing a stake of 3,800 shares — an estimated $84.8K sold.

Verition Fund Management first reported a position in KYNB in Q3 2017 and held it in 9 quarters. The position peaked at $4.85M in Q4 2021. 70 funds tracked by Wall St. Rank hold KYNB as of Q3 2024.

  • Verition Fund Management reported no remaining Kyntra Bio position as of Q3 2024 after selling out during the quarter.
  • Verition Fund Management sold 3,800 Kyntra Bio shares in Q3 2024, an estimated $84.8K.
  • Verition Fund Management first reported a position in Kyntra Bio in Q3 2017 and held it in 9 quarters.
  • Verition Fund Management's Kyntra Bio position peaked at $4.85M in Q4 2021.
  • 70 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2024.

Based on Verition Fund Management's 13F filing for Q3 2024, filed 14 Nov 2024.